Spherical cocrystallization (SCC),
an integrated crystal and particle
engineering approach, was successfully applied to generate spherical
cocrystal agglomerates (SCA) between a poorly soluble drug, griseofulvin
(GSF) and acesulfame (Acs). The SCC process consists of two steps:
(1) GSF-Acs cocrystal formation by reaction crystallization in a slurry;
(2) agglomeration by adding a bridging liquid. The obtained SCA exhibited
superior mechanical and powder properties over GSF. Inclusion of a
small amount (<1%) HPC in the agglomerates improved both the tabletability
and dissolution performance. Using the SCA, a high GSF loading (55.7%)
direct compression tablet formulation was successfully developed,
which exhibited much improved manufacturability and drug release property
over GSF based tablet formulation.